Who is sponsoring NCT03705299?

NCT03705299 is sponsored by The Cooper Health System.

What drugs are being tested in NCT03705299?

Interventions in NCT03705299: Non-Invasive CVP vs Standard CVP.

What condition does NCT03705299 study?

NCT03705299 studies Central Venous Pressure.

Is NCT03705299 still recruiting?

NCT03705299 is currently completed. Last updated 15 October 2018.

Last reviewed 2018-10-15 · How we verify

NCT03705299

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non-Invasive CVP Method to Standard CVP Method

Completed NA Last updated 15 October 2018

What this trial tests

NA trial testing Non-Invasive CVP vs Standard CVP in Central Venous Pressure in 40 participants. Completed in 6 April 2018.

Timeline

12 November 2012

Primary endpoint
6 April 2018

6 April 2018

Quick facts

Lead sponsor	The Cooper Health System
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	40
Start date	12 November 2012
Primary completion	6 April 2018
Estimated completion	6 April 2018

Drugs / interventions tested

Non-Invasive CVP vs Standard CVP

Conditions studied

Central Venous Pressure — all drugs for Central Venous Pressure →

Sponsor

The Cooper Health System — full company profile →

Who can join

18 and older, any sex, with Central Venous Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, comparative, internally controlled device study that will enroll a total of 100 adult patients that require the placement of central venous catheter and CVP monitoring to assess volume status and cardiac preload.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Central Venous Pressure

Currently open trials in the same condition.

NCT06885073 — Non-invasive Central Venous Pressure Estimation in Pediatric Patients · NA · recruiting
NCT06237751 — Preoperative Sildenafil Administration for Hepatectomy · NA · recruiting

Other The Cooper Health System trials

Trials by the same sponsor.

NCT07296120 — RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients · Phase 4 · not yet recruiting
NCT07042048 — Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization · NA · not yet recruiting
NCT06462781 — Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1 · Phase 1 · completed
NCT05974423 — Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair · Phase 4 · unknown
NCT06398366 — Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03705299 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Cooper Health System
Last refreshed: 15 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03705299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing